Gain Therapeutics Stock Price History

GANX Stock  USD 2.47  0.09  3.78%   
If you're considering investing in Gain Stock, it is important to understand the factors that can impact its price. As of today, the current price of Gain Therapeutics stands at 2.47, as last reported on the 20th of March, with the highest price reaching 2.53 and the lowest price hitting 2.33 during the day. Gain Therapeutics appears to be very risky, given 3 months investment horizon. Gain Therapeutics holds Efficiency (Sharpe) Ratio of 0.15, which attests that the entity had a 0.15 % return per unit of risk over the last 3 months. By evaluating Gain Therapeutics' technical indicators, you can evaluate if the expected return of 0.97% is justified by implied risk. Please utilize Gain Therapeutics' Risk Adjusted Performance of 0.1078, downside deviation of 4.68, and Market Risk Adjusted Performance of 3.25 to validate if our risk estimates are consistent with your expectations.
  
At this time, Gain Therapeutics' Other Stockholder Equity is fairly stable compared to the past year. Common Stock is likely to rise to 1,957 in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 11.9 M in 2025. . At this time, Gain Therapeutics' Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to rise to 3.20 in 2025, whereas Price To Sales Ratio is likely to drop 842.38 in 2025. Gain Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1544

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsGANX
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 6.25
  actual daily
55
55% of assets are less volatile

Expected Return

 0.97
  actual daily
19
81% of assets have higher returns

Risk-Adjusted Return

 0.15
  actual daily
12
88% of assets perform better
Based on monthly moving average Gain Therapeutics is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Gain Therapeutics by adding it to a well-diversified portfolio.
Price Book
7.1245
Enterprise Value Ebitda
(1.55)
Price Sales
925.9162
Shares Float
25.2 M
Wall Street Target Price
7.3333

Gain Therapeutics Stock Price History Chart

There are several ways to analyze Gain Stock price data. The simplest method is using a basic Gain candlestick price chart, which shows Gain Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceFebruary 14, 20252.73
Lowest PriceDecember 18, 20241.54

Gain Therapeutics March 20, 2025 Stock Price Synopsis

Various analyses of Gain Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Gain Stock. It can be used to describe the percentage change in the price of Gain Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Gain Stock.
Gain Therapeutics Price Rate Of Daily Change 1.04 
Gain Therapeutics Price Action Indicator 0.09 
Gain Therapeutics Accumulation Distribution 23,792 
Gain Therapeutics Price Daily Balance Of Power 0.45 

Gain Therapeutics March 20, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Gain Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Gain Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Gain Stock and then apply it to test your longer-term investment strategies against Gain.

Gain Stock Price History Data

The price series of Gain Therapeutics for the period between Fri, Dec 20, 2024 and Thu, Mar 20, 2025 has a statistical range of 1.19 with a coefficient of variation of 14.59. Under current investment horizon, the daily prices are spread out with arithmetic mean of 2.11. The median price for the last 90 days is 2.14.
OpenHighLowCloseVolume
03/19/2025 2.45  2.53  2.33  2.47  300,975 
03/18/2025 2.40  2.44  2.30  2.38  193,593 
03/17/2025 2.14  2.41  2.14  2.40  643,854 
03/14/2025 2.25  2.29  2.10  2.11  332,805 
03/13/2025 2.14  2.21  2.07  2.20  246,017 
03/12/2025 1.95  2.16  1.92  2.11  169,504 
03/11/2025 1.86  1.95  1.81  1.95  162,459 
03/10/2025 1.90  2.00  1.78  1.86  243,556 
03/07/2025 1.97  1.97  1.81  1.88  127,814 
03/06/2025 1.80  1.89  1.78  1.80  114,557 
03/05/2025 1.97  1.99  1.54  1.85  310,428 
03/04/2025 1.86  2.05  1.67  1.94  368,347 
03/03/2025 2.12  2.13  1.92  1.95  201,861 
02/28/2025 2.00  2.15  1.91  2.13  109,450 
02/27/2025 2.00  2.05  1.90  1.90  258,539 
02/26/2025 1.94  2.06  1.89  2.00  238,828 
02/25/2025 2.06  2.14  1.84  1.92  496,927 
02/24/2025 2.28  2.40  2.00  2.08  472,095 
02/21/2025 2.60  2.60  2.16  2.27  175,782 
02/20/2025 2.40  2.48  2.25  2.34  320,115 
02/19/2025 2.49  2.64  2.30  2.42  168,669 
02/18/2025 2.81  2.81  2.47  2.51  350,424 
02/14/2025 2.61  2.78  2.55  2.73  257,120 
02/13/2025 2.57  2.57  2.44  2.56  121,268 
02/12/2025 2.35  2.52  2.30  2.51  116,074 
02/11/2025 2.52  2.58  2.38  2.41  126,634 
02/10/2025 2.60  2.60  2.40  2.51  200,697 
02/07/2025 2.68  2.75  2.43  2.61  357,438 
02/06/2025 2.53  2.70  2.42  2.64  489,795 
02/05/2025 2.24  2.45  2.20  2.44  255,822 
02/04/2025 2.20  2.25  2.10  2.21  109,465 
02/03/2025 2.06  2.17  1.98  2.16  248,920 
01/31/2025 2.19  2.29  2.10  2.13  112,407 
01/30/2025 2.10  2.26  2.05  2.20  266,079 
01/29/2025 2.08  2.14  2.01  2.09  192,070 
01/28/2025 2.12  2.17  2.03  2.08  111,600 
01/27/2025 2.15  2.22  1.96  2.14  317,025 
01/24/2025 2.22  2.30  2.16  2.20  71,013 
01/23/2025 2.14  2.25  2.00  2.23  208,799 
01/22/2025 2.20  2.25  2.06  2.13  119,756 
01/21/2025 2.25  2.25  2.03  2.18  134,278 
01/17/2025 2.44  2.47  2.20  2.28  272,752 
01/16/2025 2.19  2.39  2.15  2.37  108,482 
01/15/2025 2.15  2.20  2.09  2.14  88,793 
01/14/2025 2.20  2.28  2.06  2.08  87,645 
01/13/2025 2.36  2.36  2.15  2.19  137,506 
01/10/2025 2.47  2.47  2.16  2.30  235,885 
01/08/2025 2.40  2.50  2.23  2.44  262,588 
01/07/2025 2.42  2.50  2.13  2.27  208,380 
01/06/2025 2.53  2.53  2.28  2.44  183,339 
01/03/2025 2.38  2.53  2.25  2.43  360,031 
01/02/2025 2.15  2.65  2.14  2.32  675,068 
12/31/2024 2.26  2.29  1.97  2.16  443,299 
12/30/2024 1.86  2.19  1.84  2.18  531,274 
12/27/2024 1.58  1.88  1.55  1.76  559,830 
12/26/2024 1.60  1.66  1.57  1.60  188,368 
12/24/2024 1.59  1.61  1.54  1.59  111,397 
12/23/2024 1.59  1.64  1.56  1.57  116,348 
12/20/2024 1.55  1.70  1.50  1.56  150,758 
12/19/2024 1.55  1.73  1.51  1.57  230,285 
12/18/2024 1.64  1.67  1.50  1.54  344,497 

About Gain Therapeutics Stock history

Gain Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Gain is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Gain Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Gain Therapeutics stock prices may prove useful in developing a viable investing in Gain Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding15 M11.9 M
Net Loss-15.8 M-15 M

Gain Therapeutics Quarterly Net Working Capital

9.15 Million

Gain Therapeutics Stock Technical Analysis

Gain Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Gain Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Gain Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Competition Analyzer Now

   

Competition Analyzer

Analyze and compare many basic indicators for a group of related or unrelated entities
All  Next Launch Module

Gain Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Gain Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Gain Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Gain to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Gain Stock Analysis

When running Gain Therapeutics' price analysis, check to measure Gain Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gain Therapeutics is operating at the current time. Most of Gain Therapeutics' value examination focuses on studying past and present price action to predict the probability of Gain Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gain Therapeutics' price. Additionally, you may evaluate how the addition of Gain Therapeutics to your portfolios can decrease your overall portfolio volatility.